Cornerstone Select Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.28M Buy
25,523
+2,762
+12% +$323K 1.38% 20
2026
Q1
$2.74M Buy
22,761
+988
+5% +$114K 1.71% 14
2025
Q4
$2.29M Buy
21,773
+957
+5% +$89.8K 1.59% 18
2025
Q3
$1.75M Buy
20,816
+3,003
+17% +$247K 1.28% 31
2025
Q2
$1.41M Buy
17,813
+757
+4% +$60.2K 1.24% 29
2025
Q1
$1.53M Buy
17,056
+2,154
+14% +$201K 1.45% 24
2024
Q4
$1.48M Buy
+14,902
New +$1.54M 1.43% 22

Other funds holding MRK

Cornerstone Select Advisors's MRK Position: Q2 2026 in Review

Cornerstone Select Advisors increased its Merck (MRK) stake by 12% in Q2 2026, buying an estimated $323K and bringing the position to 25,523 shares worth $3.28M. The position accounts for 1.38% of the portfolio, ranked #20.

Cornerstone Select Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cornerstone Select Advisors held 25,523 shares of Merck worth $3.28M as of Q2 2026.
  • Cornerstone Select Advisors bought 2,762 Merck shares in Q2 2026, an estimated $323K.
  • Merck made up 1.38% of Cornerstone Select Advisors's portfolio in Q2 2026, its #20 holding.
  • Cornerstone Select Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cornerstone Select Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.